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   ABSTRACT 
 
Background: Thalassemia is a hereditary disea-
se in which the sufferer is unable to produce suf-
ficient amounts of hemoglobin, causing impaired 
function of red blood cells and shortened red 
blood cell age. Thalassemia sufferers are spread 
all over the world, and thalassemia is one of the 
health problems in the world. Therapy in patients 
with thalassemia is with routine blood trans-
fusions. One side effect of repeated transfusions 
is iron overload which causes deposits of iron in 
the endocrine glands. This study aimed to deter-
mine the relationship between ferritin levels with 
blood calcium levels in patients with β major 
thalassemia. 
Subjects and Method: This was a cross-sec-
tional study conducted at Dr. Moewardi, Sura-
karta, from June to November 2017. Samples of 
49 patients with thalassemia β major aged 5-10 
years were selected using consecutive sampling. 
The dependent variable is blood calcium levels. 
The independent variable is ferritin level. Data 
were analyzed with Chi Square test. 
Results: High ferritin levels reduce calcium level 
in pediatric thalassemia β major patients, but not 
statistically significant (OR = 0.27; 95% CI = 0.04 
to 1.64; p = 0.134). 
Conclusion: High ferritin levels decrease with 
calcium levels in pediatric thalassemia β major 
patients, but not statistically significant. 
 




Andhika Trisna Putra. Department of Pediatrics, 
Faculty of Medicine, Universitas Sebelas Maret/ 




Cite this as: 
Iskandar NA, Salimo H, Moelyo AG (2020). The Relationship between Ferritin Levels and Calciumin Patients 
with Thalassemia β Major. Indones J Med. 05(02): 137-141. https://doi.org/10.26911/theijmed.2020.05.02.07 
Indonesian Journal of Medicine is licensed under a Creative Commons  
Attribution-NonCommercial-ShareAlike 4.0 International License. 
 
BACKGROUND 
Thalassemia is a disease that has spread 
throughout the world, and is one of the 
world's health problems. Thalassemia causes 
anemia and requires routine blood trans-
fusions. Meanwhile, in Indonesia the number 
of thalassemia patients until 2009 rose to 8, 
3% from 3,653 patients recorded in 2006 
(Capellini et al., 2014). 
One side effect of repeated transfusions 
is iron overload which causes deposits of iron 
in the endocrine glands and important 
organs such as the heart and kidneys. One 
parameter that can be used to assess iron 
overload is serum ferritin levels (Nancy, 20-
14; Leecharoenkiat, 2016). 
Several studies in Saudi Arabia report-
ed the prevalence of hypocalcemia in beta-
thalassemia major patients increased from 
21% to 41% from 2000 to 2008 (Aleem et al., 
2000; Najafipour et al., 2008).  
In 2012, the incidence of hypocalcemia 
in Iran patients with beta major thalassemia 
was reported to be at 22% (Mirhosseini et al., 
2013). There is a relationship between ferri-
tin levels with hypocalcemia in patients with 
thalassemia β major. However ferritin levels 
are not related to PTH levels and vitamin D 
(Aleem et al., 2000; Adil et al., 2012). This 
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study aims to determine the relationship 
between ferritin levels with blood calcium 
levels in patients with β major thalassemia. 
 
SUBJECTS AND METHOD 
1. Study Design 
This study was an observational analytic 
cross-sectional design conducted at the Hos-
pital Dr. Moewardi Surakarta, Java, Central. 
2. Population dan Sample 
The target population is pediatric patients 
with thalassemia β major. Affordable popula-
tion is pediatric thalassemia major β patients 
who are in Dr. Moewardi Hospital Surakarta 
between June 2017 to November 2017. The 
sample was 49 patients with β major thalas-
semia aged 5-10 years who were selected by 
consecutive sampling. 
3. Study Variables 
The dependent variable is calcium levels. The 
independent variable is ferritin content.  
4. Operational Definition of Variables 
Calcium level was examined by the ion se-
lective electrode method using the ROCHE 
9180 Eletrolyte Analyzer machine. 
Blood ferritin levels were calculated by 
the ELISA method using the VIDAS machine. 
Nutritional status was determined by 
measuring Mid-upper Arm Circumference 
(MUAC). The measurement were expressed 
in centimeters and plot into the MUAC curve 
according to age. 
SGOT and SGPT levels were examined 
using enzymatic methods using Siemens Ad-
via 1800.   
5. Study Instruments 
All children who met the inclusion criteria 
were taken as research subjects. Parents/ 
guardians of the research subjects were given 
an explanation and requested written appro-
val. Data is taken from interviews with pa-
rents/guardians and from medical records 
regarding the history of current illness, and 
recall diets. Analysis of the relationship bet-
ween ferritin levels and calcium levels was 
also carried out. 
6. Data Analysis 
Characteristics of continuous data samples 
are described in n, mean, and SD. Characteri-
stics of categorical data samples are descri-
bed in n and%. Comparison of ferritin levels 
(%) and calcium levels (%) were analyzed by 
Chi square test. 
7. Research Ethic 
This study was approved by the Board of 
Health Research Ethics Commission of Dr. 
Moewardi Hospital / Sebelas Maret Universi-




A. Univariate analysis 
Table 1 shows the characteristics of conti-
nuous data sample data. Table 1 shows that 
the level of ureum in patients with thalas-
semia β major average 20.48 (Mean = 20.48; 
SD= 6.94), mean creatinine level is 0.47 
(Mean= 0.47; SD = 0.97), average SGPT level 
is 50.61 (Mean=50.61; SD=39.47), the ave-
rage SGOT level is 47.22 (Mean=47.22; SD = 
62.23), the average calcium level is 1.20 
(Mean= 1.20; SD= 0.10), and the average 
ferritin level is 3,112.24 (Mean = 3,112.24; SD 
= 1,647.15). 
Table 2 shows the characteristics of 
categorical data samples. Table 2 shows that 
the majority of patients were female (63.3%), 
and had normal nutritional status (65.3%). 
B. The result of bivariate analysis  
Table 3 shows the results of comparison of 
ferritin levels with calcium levels in pediatric 
patients with thalassemia major at Dr Moe-
wardi Hospital Surakarta. Patients with high 
ferritin levels tend to have low calcium levels 
(34.88%) compared to patients with normal 
ferritin levels (66.67%).  
High ferritin levels reduce calcium 
levels 0.27 times than normal ferritin levels 
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(OR = 0.27; 95% CI = 0.04 to 1.64; p = 0.134). 
Table 1. Characteristics of Samples (Continuous Data) 
Characteristics Mean SD 
Ereum 20.48 6.94 
Creatinine 0.47 0.97 
SGPT 50.61 39.47 
SGOT 47.22 62.23 
Calcium intake 346 429 
Calcium 1.20 0.10 
Ferritin (ng/dl) 3,112.24 1,647.15 
 
Table 2. Sample Characteristics (Categorical Data) 
Characteristics n % 
Gender   
Female 31 63.3% 
Male 18 36.7% 
Nutritional Status    
Lacking 17 34.7% 
Normal 32 65.3% 
  






p Normal Low Lower 
Limit 
Upper 
Limit n % n % 
Normal 2 33.33 4 66.67 0.27 0.04 1.64 0.134 
High 28 65.12 15 34.88     
 
DISCUSSION 
Data characteristic samples showed that of 
49 patients, there were 43 patients who had 
high serum ferritin, and 6 patients had nor-
mal serum ferritin. The majority of patients 
with high serum ferritin is in accordance with 
several previous studies which showed that 
patients with B-Thalassemia have higher se-
rum ferritin than healthy people (Attia et al., 
2011; Karim et al., 2016;). There are 6 res-
pondents who have normal serum ferritin 
suspected to be caused by blood transfusion 
factor itself, as described in a study (Taher 
and Saliba, 2017). First, it is possible that 
patients who have low serum ferritin are 
transfused-dependent thalassemia patients, 
but have not been transfused for a long time, 
giving the body time to excrete ferritin. Se-
condly, it is possible that there are patients 
who have a profile as thalassemia patients 
who are not transfusion dependent, so that 
the patient's serum ferritin does not increase. 
Previous research states that patients 
with B-Thalassemia have lower calcium levels 
than normal patients (Karim et al., 2016). A 
study also showed that patients with B-
Thalassemia will experience hypoparathyro-
idism where the lack of PTH production will 
reduce the absorption of calcium from the 
gastrointestinal tract and reduce calcium le-
vels in serum (Lertsuwan et al., 2018). Other 
studies have also shown that patients without 
blood disorders will have better bone density 
than patients with blood disorders (Lee et al., 
2013). The same research also explains that 
there are several other factors that can influ-
ence calcium levels in a person. First, a high-
er calcium intake in a person will increase 
calcium levels in that person. The absence of 
dietary restrictions or calcium diet question-
naires to determine the calcium intake of 
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respondents allegedly caused a high percen-
tage of respondents with normal calcium. Se-
cond, it is a factor of the PTH hormone. The 
absence of examination of PTH levels and 
restriction of respondents with normal para-
thyroid function is thought to have caused 
the inclusion of respondents with normal se-
rum PTH. Normal PTH serum, will cause cal-
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